메뉴 건너뛰기




Volumn 66, Issue 1, 2008, Pages 30-33

Stroke in patients with sickle cell disease: Clinical and neurological aspects

Author keywords

Neurological manifestations; Sickle cell anemia; Stroke

Indexed keywords

DEFEROXAMINE;

EID: 42049118965     PISSN: 0004282X     EISSN: 16784227     Source Type: Journal    
DOI: 10.1590/S0004-282X2008000100008     Document Type: Article
Times cited : (9)

References (14)
  • 1
    • 0031815787 scopus 로고    scopus 로고
    • Stroke in children and sickle-cell disease: Baltimore-Washington Cooperative Young Stroke Study
    • Earley CJ, Kittner SJ, Feeser BR, et al. Stroke in children and sickle-cell disease: Baltimore-Washington Cooperative Young Stroke Study. Neurology 1998;51:169-176.
    • (1998) Neurology , vol.51 , pp. 169-176
    • Earley, C.J.1    Kittner, S.J.2    Feeser, B.R.3
  • 2
    • 0031965089 scopus 로고    scopus 로고
    • Cerebrovascular accidents in sickle cell disease: Rates and risk factors
    • Ohene-Frempong K, Weiner SJ, Sleeper LA, et al. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood 1998;91:288-294.
    • (1998) Blood , vol.91 , pp. 288-294
    • Ohene-Frempong, K.1    Weiner, S.J.2    Sleeper, L.A.3
  • 4
    • 0025797297 scopus 로고
    • Stroke in sickle cell disease: Demographic, clinical and therapeutic considerations
    • Ohene-Frempong K. Stroke in sickle cell disease: demographic, clinical and therapeutic considerations. Semen Hematol 1991;28:213.
    • (1991) Semen Hematol , vol.28 , pp. 213
    • Ohene-Frempong, K.1
  • 7
    • 0242290075 scopus 로고    scopus 로고
    • Brain injury in children with sickle cell disease: Prevalence and etiology
    • Steen RG, Xiong X, Langston MD, Helton KJ. Brain injury in children with sickle cell disease: prevalence and etiology. Ann Neurol 2003;54:564-572.
    • (2003) Ann Neurol , vol.54 , pp. 564-572
    • Steen, R.G.1    Xiong, X.2    Langston, M.D.3    Helton, K.J.4
  • 9
    • 0027406484 scopus 로고
    • Developmental screening in young children with sickle cell disease: Results of a cooperative study
    • Wang WC, Grover R, Gallagher D, Espeland M, Fandal A. Developmental screening in young children with sickle cell disease: results of a cooperative study. Am J Pediatr Hematol Oncol 1993;15:87-91.
    • (1993) Am J Pediatr Hematol Oncol , vol.15 , pp. 87-91
    • Wang, W.C.1    Grover, R.2    Gallagher, D.3    Espeland, M.4    Fandal, A.5
  • 10
    • 0036217530 scopus 로고    scopus 로고
    • Neurocognitive development of young children with sickle cell disease through three years of age
    • Thompson RJ Jr, Gustafson KE, Bonner MJ, Ware RE. Neurocognitive development of young children with sickle cell disease through three years of age. J Pediatr Psychol 2002;27:235-244.
    • (2002) J Pediatr Psychol , vol.27 , pp. 235-244
    • Thompson Jr, R.J.1    Gustafson, K.E.2    Bonner, M.J.3    Ware, R.E.4
  • 11
    • 15844366370 scopus 로고    scopus 로고
    • Cognitive functioning and brain magnetic resonance imaging in children with sickle cell disease
    • Armstrong FD, Thompson RJ, Jr, Wang W, et al. Cognitive functioning and brain magnetic resonance imaging in children with sickle cell disease. Pediatrics 1996;97:864-870.
    • (1996) Pediatrics , vol.97 , pp. 864-870
    • Armstrong, F.D.1    Thompson Jr, R.J.2    Wang, W.3
  • 12
    • 0032474692 scopus 로고    scopus 로고
    • Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography
    • Adams RJ, McKie VC, Hsu L, et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med 1998;339:5-11.
    • (1998) N Engl J Med , vol.339 , pp. 5-11
    • Adams, R.J.1    McKie, V.C.2    Hsu, L.3
  • 13
    • 0008801734 scopus 로고
    • High risk of recurrent stroke after discontinuance of five to twelve years of transfusion therapy in patients with sickle cell disease
    • Wang WC, Kavaar EH, Tonkin IC. High risk of recurrent stroke after discontinuance of five to twelve years of transfusion therapy in patients with sickle cell disease. J Pediatr 1991;96:205-208.
    • (1991) J Pediatr , vol.96 , pp. 205-208
    • Wang, W.C.1    Kavaar, E.H.2    Tonkin, I.C.3
  • 14
    • 0036566530 scopus 로고    scopus 로고
    • Moyamoya syndrome in childhood sickle cell disease: A predictive factor for recurrent cerebrovascular events
    • Dobson SR, Holden KR, Nietert PJ, et al. Moyamoya syndrome in childhood sickle cell disease: A predictive factor for recurrent cerebrovascular events. Blood 2002;99:3144-3150.
    • (2002) Blood , vol.99 , pp. 3144-3150
    • Dobson, S.R.1    Holden, K.R.2    Nietert, P.J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.